Vanberra Signal

Benevolent

Curated by Signal

AI-powered platform for drug discovery and development

Overview

AI-powered platform for drug discovery and development. The company aims to discover and develop an AI-enabled drug discovery platform for pharmaceutical solutions. The company's technology platform includes JACS Judgement Augmented Correlation System that learning-based AI which is used to produce medical data for the discovery and development of drugs. The company has developed integrated and complementary subsidiaries ‘BenevolentBio’ that focuses on the application of its technology platform in human health and veterinary medicine.

Key facts

Founded
2013

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Health Technology companies
  • Provider of a digital platform for quality management and staff communication

    Health TechnologyLondon, United Kingdom
  • Research assistance software solutions

    Health TechnologyLondon, United Kingdom
  • Provider of an online information platform for parenting and baby advice

    Health TechnologyLondon, United Kingdom

About Benevolent

What does Benevolent do?

AI-powered platform for drug discovery and development.

Where is Benevolent headquartered?

Benevolent is headquartered in London, United Kingdom.

When was Benevolent founded?

Benevolent was founded in 2013.

Which sector is Benevolent in?

Benevolent operates in Health Technology.

Who are Benevolent's competitors?

Companies similar to Benevolent include ImproveWell, Digital Science, and Your Baby Club.